Currently out of the existing stock ratings of Jordan Abrams, 2 are a BUY (100%).

Jordan Abrams

Work Performance Price Targets & Ratings Chart

Analyst Jordan Abrams, Previously, Jordan Abrams worked at CANTOR FITZGERALD.

Jordan Abrams’s has documented 4 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on HTGM, HTG Molecular Diagnostics at 08-Apr-2019.

Wall Street Analyst Jordan Abrams

Analyst best performing recommendations are on HTGM (HTG MOLECULAR DIAGNOSTICS).
HTGM HTG Molecular Diagnostics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 26-Mar-2020

$6

$5.65 (1614.29%)

$6

3 years 5 months 23 days ago
(19-Apr-2023)

1/3 (33.33%)

$2.85 (90.48%)

708

Buy Since 11-May-2020

$42

$41.65 (11900.00%)

$180

4 years 2 months 20 days ago
(22-Jul-2022)

0/4 (0%)

$30.34 (260.21%)

Buy

$3

$2.45 (445.45%)

$8

4 years 6 months 12 days ago
(30-Mar-2022)

1/6 (16.67%)

$1.21 (41.19%)

3

Buy Since 19-Apr-2017

7 years 1 months 29 days ago
(13-Aug-2019)

0/2 (0%)

$455.4 (56.60%)

Buy Since 20-Sep-2018

$1080

$1079.65 (308471.44%)

$1260

7 years 6 months 4 days ago
(08-Apr-2019)

0/2 (0%)

$626.4 (138.10%)

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?